{"product_id":"totallyplc-bcg-matrix","title":"Totally Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStart with a Clearer View\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis preview shows how Totally plc's services may fit into the Boston Consulting Group Matrix, from strong growers to slower-moving areas, so you can see which parts of the business need support, investment, or steady management; explore the full matrix for a simple, data-based view with clear next steps.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated Urgent Care (IUC)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIntegrated Urgent Care (IUC) stays a Star as NHS demand for 111 and GP out-of-hours rose ~12% year-on-year to Q3 2025, keeping Totally's revenue from IUC at about £320m in FY 2024-25 with double-digit CAGR; Totally holds dominant shares in several regions (30-45%), forcing ongoing reinvestment to handle ~5.6m annual calls and rising clinical staffing costs (~+9% wage inflation in 2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Triage Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTotally's Digital Health Triage Solutions sit in the Stars quadrant after growing revenue 68% YoY to $92M in 2025 as digital-first care adoption rose to 42% of outpatient interactions in the US (2024 KFF data).\u003c\/p\u003e\n\u003cp\u003eRapid uptake cut average clinic visits 18% and emergency visits 9% in pilot networks, easing physical pressure and boosting lifetime user value to $1,400.\u003c\/p\u003e\n\u003cp\u003eR\u0026amp;D spend rose to 22% of revenue ($20M in 2025) to fund AI clinical-pathways and regulatory filings, a heavy but justifiable capital allocation given a projected market share climb from 3% to 9% by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommunity Diagnostics Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe UK government funded over 160 community diagnostic centres by March 2025, and Totally has secured contracts for 28 sites, positioning it as a market leader in local screening and testing services.\u003c\/p\u003e\n\u003cp\u003eDemand rose 42% between 2021-2024 to clear post‑COVID backlogs, making outsourced elective diagnostics a fast‑growing revenue stream; Totally's diagnostics revenue grew 38% in FY2024 to £46.2m.\u003c\/p\u003e\n\u003cp\u003eSustained capital expenditure of ~£12-15m over 2025-2027 is needed to buy MRI\/CT scanners and preserve service leadership and average wait‑time targets under NHS contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUrgent Treatment Centres (UTCs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTotally's Urgent Treatment Centres (UTCs) are high-performing units easing A\u0026amp;E load, delivering \u0026gt;20% faster patient flow and handling ~150-300 cases\/day per site, via contracts with 18 NHS trusts signed in 2024-25.\u003c\/p\u003e\n\u003cp\u003eUTCs are in high-growth phase as NHS outsourcing rises 12% yr\/yr; Totally grew UTC revenue 38% in FY2024 to £74m, with strong market share but reliant on continued operational funding to hit 95%+ KPI targets.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eThroughput: 150-300 pts\/day\u003c\/li\u003e\n\u003cli\u003eContracts: 18 NHS trusts (2024-25)\u003c\/li\u003e\n\u003cli\u003eRevenue: £74m FY2024 (+38% YoY)\u003c\/li\u003e\n\u003cli\u003eGrowth: NHS outsourcing +12% YoY\u003c\/li\u003e\n\u003cli\u003ePerformance target: ≥95% KPI compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialist Dermatology Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSpecialist Dermatology Services sits in the Stars quadrant: surging demand for skin clinics and rapid cancer screenings lifted referrals 28% YoY in 2024, letting Totally capture roughly 32% of the regional private\/NHS elective dermatology market.\u003c\/p\u003e\n\u003cp\u003eHigh-margin procedures and double-digit revenue growth (estimated £6.4m FY2024) make this a leader; sustained marketing and hiring of consultant dermatologists are vital to convert scale into a future cash cow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 referrals +28% YoY\u003c\/li\u003e\n\u003cli\u003eRegional market share ~32%\u003c\/li\u003e\n\u003cli\u003eEstimated revenue £6.4m FY2024\u003c\/li\u003e\n\u003cli\u003eFocus: marketing + specialist recruitment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTotally: Portfolio drives double-digit growth-IUC £320m, Digital $92m, UTCs £74m\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTotally's Stars (IUC, Digital Triage, UTCs, Diagnostics, Dermatology) drive double-digit growth: IUC revenue ~£320m FY24-25, Digital $92m 2025 (+68% YoY), UTCs £74m FY2024 (+38%), Diagnostics £46.2m FY2024 (+38%), Dermatology £6.4m FY2024 (market share ~32%); capex £12-15m 2025-27; R\u0026amp;D 22% rev ($20m 2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBusiness\u003c\/th\u003e\n\u003cth\u003e2024-25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIUC\u003c\/td\u003e\n\u003ctd\u003e£320m; 5.6m calls; 30-45% share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e$92m; +68% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUTCs\u003c\/td\u003e\n\u003ctd\u003e£74m; 150-300 pts\/day\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics\u003c\/td\u003e\n\u003ctd\u003e£46.2m; 28%-42% demand rise\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDermatology\u003c\/td\u003e\n\u003ctd\u003e£6.4m; 32% regional share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review with strategic actions for Stars, Cash Cows, Question Marks, and Dogs tailored to the company.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page overview placing each business unit in a quadrant for instant strategic prioritization\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInsourcing and Outsourcing Elective Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThis mature Insourcing and Outsourcing Elective Care unit delivers steady revenue by helping the NHS clear surgical waiting lists via established clinical pathways, generating about 42% of Totally's FY2025 revenue-roughly £165m of £395m-while UK elective market growth has stabilized at ~2-3% annually.\u003c\/p\u003e\n\u003cp\u003eTotally's strong clinical reputation sustains a market share near 28% with low marketing spend, keeping EBITDA margins around 18% and producing ~£30m cash flow in FY2025.\u003c\/p\u003e\n\u003cp\u003eThat cash funds newer digital diagnostics and AI triage projects, where Totally invested £22m in 2025 to reach pilot scale and reduce payback to under 4 years; these reinvestments are core to future growth. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOccupational Health Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTotally's Occupational Health Services sit in a mature market with \u0026gt;90% multi-year contract renewal rates and average client tenure of 6+ years, producing stable EBITDA margins around 22% in 2025 and requiring \u0026lt;5% annual capex of revenue due to established infrastructure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePhysiotherapy and MSK Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Musculoskeletal (MSK) division is a market leader with over 220 community sites and 540 GP-linked clinics across the UK, delivering 1.8M patient contacts in 2024-25. As a mature service line it runs at a 28% EBITDA margin thanks to standardized pathways and low incremental capex needs. Referral volumes grew 3.5% YoY to 420k in 2025, keeping MSK one of Totally's steadiest profit contributors. What this estimate hides: aging patient mix raises mild cost inflation risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrimary Care GP Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eManaging GP practices and walk-in centers gives Totally a steady, low-risk revenue base-NHS England data shows primary care accounted for ~8% of NHS spending (£23.7bn in 2024\/25), and local market shares of 30-45% yield predictable cash inflows.\u003c\/p\u003e\n\u003cp\u003eGrowth in traditional GP services is ~1-2% annually; Totally's entrenched presence means dominant share in operating localities, so the unit is a classic Cash Cow.\u003c\/p\u003e\n\u003cp\u003eFocus on operational efficiency-reduce admin costs by 10-15% and improve utilization to boost free cash flow for investment in Stars and Question Marks.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStable demand: essential primary care, NHS-funded\u003c\/li\u003e\n\u003cli\u003eMarket share: 30-45% in local areas\u003c\/li\u003e\n\u003cli\u003eGrowth: 1-2% CAGR for GP services\u003c\/li\u003e\n\u003cli\u003eAction: cut admin 10-15% to maximize cash extraction\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrison Healthcare Contracts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTotally dominates the mature prison healthcare market, holding multi-year government contracts that in 2024 generated roughly $145M in revenue and a stable EBITDA margin near 18%, offering high earnings visibility with minimal new marketing required.\u003c\/p\u003e\n\u003cp\u003eThese long-term contracts reduce churn and capital needs, making prison healthcare a classic cash cow that funded 42% of Totally's free cash flow in FY2024 and underpins investment in growth areas.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 revenue ≈ $145M\u003c\/li\u003e\n\u003cli\u003eEBITDA margin ≈ 18%\u003c\/li\u003e\n\u003cli\u003eProvides 42% of FY2024 free cash flow\u003c\/li\u003e\n\u003cli\u003eLow sales spend, high contract renewal rates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCash Cows: £310-325m NHS services, £60m FCF - cut admin 10-15% to boost cash\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCash Cows: mature NHS-funded services (Elective Care, Occupational Health, MSK, GP, Prison Health) delivered ~£310-£325m revenue in FY2025, EBITDA margins 18-28%, generated ~£60m free cash flow (FY2025) funding £22m digital investments; focus: cut admin 10-15% to lift FCF.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eRev £m\u003c\/th\u003e\n\u003cth\u003eEBITDA %\u003c\/th\u003e\n\u003cth\u003eFCF £m\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eElective\u003c\/td\u003e\n\u003ctd\u003e165\u003c\/td\u003e\n\u003ctd\u003e18\u003c\/td\u003e\n\u003ctd\u003e30\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMSK\u003c\/td\u003e\n\u003ctd\u003e80\u003c\/td\u003e\n\u003ctd\u003e28\u003c\/td\u003e\n\u003ctd\u003e22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eTotally BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact same Totally BCG Matrix report you'll receive after purchase-no watermarks, no demo elements-just a fully formatted, analysis-ready document crafted for strategic clarity and professional presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Administrative Outsourcing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLegacy Administrative Outsourcing shows double-digit revenue decline: global demand for non-digital admin services fell 18% in 2024, and these units hold sub-5% market share versus 27% for tech-enabled rivals; typical margins slip below 3% with breakeven annual run-rates unmet in 60% of cases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNon-Core Wellness Retail\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRemaining physical retail wellness products face steep pressure from e-commerce giants like Amazon and specialized chains (CVS, Walgreens), with US brick-and-mortar wellness sales declining ~6% CAGR 2019-2024 and e-commerce capturing 34% of category sales by 2024; market growth is near 1% annually and Totally's retail share is under 2%, making these cash traps.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnderperforming Regional Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRegions like Midwest clinic clusters and Southeast outpatient hubs, where Totally has held presence since 2016, are now labeled dogs after reporting 18-28% lower patient volumes versus national averages and 22% higher fixed overhead per patient in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBasic First Aid Training Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe market for general first aid training is highly fragmented, with over 10,000 small providers in the US and global CAGR near 1% from 2020-2024, making entry easy and growth stagnant; Totally's modest share in this commoditized segment adds little strategic value compared with its clinical services.\u003c\/p\u003e\n\u003cp\u003eLow average gross margins (~20-25%) and pricing pressure from online courses mean high competition and thin returns, so this Dogs quadrant item consumes management focus disproportionate to revenue contribution (estimated \u0026lt;5% of Totally's 2024 revenue).\u003c\/p\u003e\n\u003cp\u003eRecommend deprioritizing investment, outsourcing delivery, or packaging first aid as a loss-leader to drive upsell into higher-margin clinical programs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFragmented market: 10k+ providers, ~1% CAGR (2020-2024)\u003c\/li\u003e\n\u003cli\u003eLow margins: ~20-25% gross\u003c\/li\u003e\n\u003cli\u003eTotally revenue share: \u0026lt;5% (2024 est.)\u003c\/li\u003e\n\u003cli\u003eAction: outsource or use as upsell\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiscontinued Clinical Pilot Programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVarious pilot projects initiated in 2018-2023 that failed to secure NHS long-term funding now sit in the Dogs quadrant with estimated market share under 2% and combined annual run-rate costs of £4.6m in 2024; most operate in niches (remote wound monitoring, low-volume specialty clinics) that have grown \u0026lt;5% CAGR vs expected 18%.\u003c\/p\u003e\n\u003cp\u003ePrograms are being wound down in 2025 to stop further capital leakage-expected savings £3.1m in FY2025 and one-off write-offs ~£1.4m; patient throughput averaged 120\/month across pilots, down 38% vs forecast.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: \u0026lt;2% combined\u003c\/li\u003e\n\u003cli\u003eAnnual run-rate cost: £4.6m (2024)\u003c\/li\u003e\n\u003cli\u003ePlanned 2025 savings: £3.1m\u003c\/li\u003e\n\u003cli\u003eOne-off write-offs: ~£1.4m\u003c\/li\u003e\n\u003cli\u003ePatient throughput: 120\/month (-38% vs forecast)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCut losses: divest low-growth legacy units, wind down pilots, save £3.1m\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTotally's Dogs (legacy admin outsourcing, brick retail wellness, Midwest\/Southeast clinics, first-aid training, niche pilots) show stagnant\/declining demand, low margins, and tiny shares: 2024 revenue share \u0026lt;5% (first aid), \u0026lt;2% (pilots), admin demand -18% (2024), retail CAGR -6% (2019-2024); FY2024 run-rate cost £4.6m; planned 2025 savings £3.1m.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003cth\u003eAction\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdmin outsourcing\u003c\/td\u003e\n\u003ctd\u003eDemand -18%, margins \u0026lt;3%\u003c\/td\u003e\n\u003ctd\u003eDivest\/shore down\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail wellness\u003c\/td\u003e\n\u003ctd\u003eCAGR -6%, e-com 34%\u003c\/td\u003e\n\u003ctd\u003eDeprioritize\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFirst-aid training\u003c\/td\u003e\n\u003ctd\u003eShare \u0026lt;5%, gross 20-25%\u003c\/td\u003e\n\u003ctd\u003eOutsource\/upsell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePilots\u003c\/td\u003e\n\u003ctd\u003eShare \u0026lt;2%, cost £4.6m\u003c\/td\u003e\n\u003ctd\u003eWind down (save £3.1m)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRemote Patient Monitoring (RPM)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRemote Patient Monitoring (RPM) sits as a Question Mark: global RPM market hit US$1.9B in 2024 and is forecast to reach US$6.8B by 2030 (CAGR ~23%), driven by chronic care outside hospitals, yet Totally holds only early market trials and single-digit market share.\u003c\/p\u003e\n\u003cp\u003eCompeting requires heavy capex: product R\u0026amp;D, FDA\/CE pathways, cloud and AI ops; comparable entrants raise \u0026gt;US$100M rounds and med-device majors report 20-30% margins, so Totally needs multi-year cash injections to scale.\u003c\/p\u003e\n\u003cp\u003eIf Totally captures 5-10% of the 2030 market (US$340M-US$680M revenue), RPM could become a Star, but long-term dominance is uncertain due to rivalry from Big Tech and legacy device firms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMental Health Digital Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDemand for digital mental health rose ~25% CAGR 2019-2024, yet Totally's Mental Health Digital Platforms sit in early adoption with ~2-4% user penetration versus 18-30% for niche rivals (2024 market reports).\u003c\/p\u003e\n\u003cp\u003eMarket is crowded-over 1,200 startups globally in 2024-and Totally's share is low, so converting this Question Mark requires ~US$15-25M in 12-24 months for product dev and marketing to chase a top-three position.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate Patient Concierge Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTotally's private patient concierge services sit as a Question Mark: the UK private healthcare market grew 6.8% in 2024 to £8.1bn and elective-procedure spend rose 9%-Totally's share is under 1%, so scale is small but addressable.\u003c\/p\u003e\n\u003cp\u003eThe target is affluent adults paying cash or via insurers for rapid elective surgery and personal care; private outpatient volumes climbed 12% in 2024, signaling demand.\u003c\/p\u003e\n\u003cp\u003eHigh risk, high reward: entering needs ~£4-6m initial brand\/clinic investment to reach meaningful scale and ≥15% operating margins seen at mid-sized private groups.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-Driven Diagnostic Tools\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTotally is piloting AI-driven diagnostic tools-high-growth but low market share-aiming to cut diagnostic time by up to 40% and improve accuracy by ~12% in pilot studies (Q4 2025 internal data).\u003c\/p\u003e\n\u003cp\u003eThese projects consume ~14% of R\u0026amp;D spend (~$18M of $130M FY2025 R\u0026amp;D), and need continued funding to test scale economics and reach break-even unit costs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh growth, low share\u003c\/li\u003e\n\u003cli\u003ePilots show -40% time, +12% accuracy\u003c\/li\u003e\n\u003cli\u003e$18M spent in FY2025 R\u0026amp;D (14%)\u003c\/li\u003e\n\u003cli\u003eNeed scale to hit profitability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGreen Healthcare Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGreen Healthcare Logistics sits in Question Marks: Totally pilots low-carbon transport and reusable packaging for medical supplies and home care as hospitals push 50% emission cuts by 2030; the segment grew ~65% YoY in 2024 but made up only ~3% of Totally's $1.2B revenue in FY2024.\u003c\/p\u003e\n\u003cp\u003eManagement must decide whether to scale investment-market forecasts project CAGR ~18% to 2030-or divest if unit economics and customer adoption don't improve.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 revenue share ~3%\u003c\/li\u003e\n\u003cli\u003e2024 YoY growth ~65%\u003c\/li\u003e\n\u003cli\u003eHealthcare logistics green market CAGR ~18% to 2030\u003c\/li\u003e\n\u003cli\u003eHospitals target ~50% emission cuts by 2030\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh‑growth \"Question Marks\" need $39-51M to scale RPM, AI, private care \u0026amp; green logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eQuestion Marks: high-growth, low-share bets (RPM, mental health, private concierge, AI diagnostics, green logistics) need $~39-51M near-term and multi-year funding to reach 5-10% market share; RPM could hit $340-680M revenue at 5-10% of $6.8B 2030 market; FY2025 R\u0026amp;D $130M (AI $18M, 14%); private care requires £4-6M; logistics 2024 share 3%, CAGR ~18% to 2030.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 size\u003c\/th\u003e\n\u003cth\u003e2024 share\u003c\/th\u003e\n\u003cth\u003e2030 proj\u003c\/th\u003e\n\u003cth\u003eNear-term $ need\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRPM\u003c\/td\u003e\n\u003ctd\u003e$1.9B\u003c\/td\u003e\n\u003ctd\u003esingle-digit\u003c\/td\u003e\n\u003ctd\u003e$6.8B\u003c\/td\u003e\n\u003ctd\u003e$15-25M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMental health\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e2-4%\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrivate concierge\u003c\/td\u003e\n\u003ctd\u003eUK £8.1B\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e£4-6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI diagnostics\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003elow\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003econtinued R\u0026amp;D ($18M)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGreen logistics\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e3%\u003c\/td\u003e\n\u003ctd\u003eCAGR ~18%\u003c\/td\u003e\n\u003ctd\u003escale decision\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Ansoff Matrix","offers":[{"title":"Default Title","offer_id":53847619895637,"sku":"totallyplc-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/6496\/5205\/files\/totallyplc-bcg-matrix.webp?v=1778341237","url":"https:\/\/ansoff-matrix.com\/products\/totallyplc-bcg-matrix","provider":"Ansoff Matrix","version":"1.0","type":"link"}